Fentanyl, Screen With Reflexed Confirmation, Urine
Also known as: Sublimaze; Abstral; Actiq; Duragesic; Fentora; lonsys; Lazanda; Subsys; Pain Management; Prescription Drug Monitoring; Labcorp MedWatch®; Medical Drug Monitoring
Use
This test is used to detect and confirm the presence of fentanyl or norfentanyl.
Special Instructions
The assay is specifically intended for pain management purposes and thus is not compliant with workplace testing requirements. Additionally, the assay's performance characteristics have been determined by Labcorp but it lacks clearance by the FDA.
Limitations
The test has been developed and its performance characteristics defined by Labcorp. It has not received clearance or approval from the FDA. As a result, interpretations should be made in consideration of this limitation. Moreover, additional reflex or confirmatory tests may be necessary, potentially extending the testing timeline.
Methodology
Immunoassay (Mass Spectrometry)
Biomarkers
LOINC Codes
- 59673-4
- 59673-4
Result Turnaround Time
1-2 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
20 mL
Minimum Volume
Not provided
Container
Urine bottle
Storage Instructions
Maintain specimen at room temperature. Stability: If arrival at lab will extend beyond 7 days then refrigerate.
Other tests from different labs that may be relevant